Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Sodium butanoate
Cat. No.:
OB0225LY-0148
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Sodium butanoate is a short-chain fatty acid salt that serves primarily as a metabolite and nutrient. It can be converted to energy in the body and is involved in a variety of metabolic pathways.
Synonym:
Sodium butyrate; Butanoic acid sodium salt; 156-54-7; Butanoic acid, sodium salt; Butyrate sodium; Butyric acid, sodium salt; Sodium n-butyrate; Sodium propanecarboxylate
CAS No.:
156-54-7
Compound CID:
5222465
Formula:
C4H7NaO2
Formula Weight:
110.09
Specification
Relative Density:
0.987 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Sodium butanoate has applications in nutritional supplementation and as a research model.
Library Information
Targets:
Histamine receptor
Receptors:
H1 receptor
Pathways:
GPCR/G protein; Neuronal signaling; Immunology/Inflammation
Plate Number:
AOCL-2
Plate Location:
g11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
1.1 mg/mL; 10 mM
Water Max Solubility:
100 mg/mL; 908.35 mM
